Hematology

In this Q&A, hematologist Dr. Kwiatkowski discusses the Food and Drug Administration approval of beti-cel (Zynteglo®), a gene therapy for beta thalassemia.

Congratulations to Garrett Brodeur, MD, recipient of the American Society of Pediatric Hematology/Oncology Distinguished Career Award.

CHOP researchers have developed a potentially safer and more effective gene therapy vector for red blood disorders.

Researchers work to enhance the body’s immune response to contain infection locally and prevent systemic bacterial spread.

Meet the four recipients of our 2019 Distinguished Research Trainee Awards at CHOP Research Institute.

The Children’s Hospital of Philadelphia’s Lacramioara Ivanciu, PhD, was one of five investigators who recently received funding through the Bayer Hemophilia Awards Program (BHAP).